1. Home
  2. LIEN vs ABEO Comparison

LIEN vs ABEO Comparison

Compare LIEN & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIEN
  • ABEO
  • Stock Information
  • Founded
  • LIEN 2021
  • ABEO N/A
  • Country
  • LIEN United States
  • ABEO United States
  • Employees
  • LIEN N/A
  • ABEO N/A
  • Industry
  • LIEN
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIEN
  • ABEO Health Care
  • Exchange
  • LIEN NYSE
  • ABEO Nasdaq
  • Market Cap
  • LIEN 294.4M
  • ABEO 277.6M
  • IPO Year
  • LIEN 2022
  • ABEO 1980
  • Fundamental
  • Price
  • LIEN $13.07
  • ABEO $6.24
  • Analyst Decision
  • LIEN
  • ABEO Strong Buy
  • Analyst Count
  • LIEN 0
  • ABEO 3
  • Target Price
  • LIEN N/A
  • ABEO $18.00
  • AVG Volume (30 Days)
  • LIEN 14.7K
  • ABEO 220.1K
  • Earning Date
  • LIEN 11-08-2024
  • ABEO 11-11-2024
  • Dividend Yield
  • LIEN 7.78%
  • ABEO N/A
  • EPS Growth
  • LIEN 5.69
  • ABEO N/A
  • EPS
  • LIEN 0.90
  • ABEO N/A
  • Revenue
  • LIEN $12,422,942.00
  • ABEO N/A
  • Revenue This Year
  • LIEN N/A
  • ABEO N/A
  • Revenue Next Year
  • LIEN N/A
  • ABEO $7,097.06
  • P/E Ratio
  • LIEN $14.31
  • ABEO N/A
  • Revenue Growth
  • LIEN 44.81
  • ABEO 147.52
  • 52 Week Low
  • LIEN $7.29
  • ABEO $3.05
  • 52 Week High
  • LIEN $13.38
  • ABEO $9.01
  • Technical
  • Relative Strength Index (RSI)
  • LIEN N/A
  • ABEO 49.81
  • Support Level
  • LIEN N/A
  • ABEO $6.04
  • Resistance Level
  • LIEN N/A
  • ABEO $6.78
  • Average True Range (ATR)
  • LIEN 0.00
  • ABEO 0.31
  • MACD
  • LIEN 0.00
  • ABEO -0.06
  • Stochastic Oscillator
  • LIEN 0.00
  • ABEO 36.49

About LIEN CHICAGO ATLANTIC BDC INC

Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Share on Social Networks: